Scandals have eroded US public's confidence in drug industry

BMJ 2004; 329 doi: 10.1136/bmj.329.7460.247 (Published 29 July 2004)
Cite this as: BMJ 2004;329:247.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jeanne Lenzer
  1. New York

    Only 13% of Americans believe that pharmaceutical companies are “generally honest and trustworthy,” putting the industry on a par with tobacco, oil, and managed care companies, a recent Harris Poll survey has found. Public confidence in drug companies has plunged harder and faster than for any other industry, the survey indicates (17 July, p 128).

    The distrust appears to be spreading to respected US medical bodies and academic journals in the wake of a spate of public controversies concerning the influence of drug companies.

    Guidelines for lowering cholesterol concentrations, issued on 12 July by the National Heart, Lung, and Blood Institute and the American Heart Association, sparked a furore when it was shown that all but one of the nine authors had financial ties to the manufacturers of …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL